Gastrointestinal involvement in patients with systemic sclerosis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 4, 2010, Pages 132-136

  Wielosz, Ewa ^a   Borys, Olga ^a   Zychowska, Iwona ^a   Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antinuclear antibodies; Esophagus; Gastrointestinal involvement; Pulmonary involvement; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ARTICLE; BARIUM MEAL; BLOATING; CONSTIPATION; DIARRHEA; DYSPHAGIA; EPIGASTRIC DISCOMFORT; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; INTESTINE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; RADIODIAGNOSIS; RETROSTERNAL PAIN; SYSTEMIC SCLEROSIS; UPPER GASTROINTESTINAL TRACT;

EID: 77952821298     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.907     Document Type: Article

References (28)

1. Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, et al. Systemic sclerosis: a world wide global analysis. Clin Rheumatol. 2009; 28: 757-765.
2. Wielosz E, Dryglewska M, Majdan M. Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis. Clin Rheumatol. 2009; 28: 955-959.
3. Wielosz E, Majdan M, Suszek D, et al. Nephrotic syndrome as a clinical manifestation of systemic sclerosis. Rheumatol Int. 2007; 27: 1087-1089. (Pubitemid 47246585)
4. Ellen CE. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006; 40: 796-1775
5. Szamosi S, Szekanecz Z, Szucs G. Gastrointestinal manifestations in Hungarian scleroderma patients. Rheumatol Int. 2006; 26: 1120-1124. (Pubitemid 44450848)
6. Ntoumazios SK, Voulgari PV, Potsis K, et al. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006; 36: 173-181. (Pubitemid 44767593)
7. Olivé A, Juncosa S, Evison G, Maddison PJ. Air in the oesophagus: A sign of oesophageal involvement in systemic sclerosis. Clin Rheumatol. 1995; 14: 319-321.
8. Marie I, Levesque H, Ducrotté P, et al. Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol. 2001; 96: 77-83. (Pubitemid 32104811)
9. Lock G, Zeuner M, Lang B, et al. Anorectal function in systemic sclerosis: correlation with esophageal dysfunction? Dis Colon Rectum. 1997; 40: 1328-1335.
10. Wegener M, Adamek RJ, Wedmann B, et al. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci. 1994; 39: 2209-2215. (Pubitemid 24341636)
11. Fulp SR, Castell DO. Scleroderma esophagus. Dysphagia. 1990; 5: 204-210.
12. Plastiras SC, Tzivras M, Vlachoyiannopoulos PG. Severe gastrointestinal involvement in systemic sclerosis. Clin Rheumatol. 2007; 26: 1025-1026. (Pubitemid 46951321)
13. Folwaczny C, Voderholzer W, Riepl RL, Schindlbeck N. [Clinical aspects, pathophysiology, diagnosis and therapy of gastrointestinal manifestations of progressive systemic scleroderma]. Z Gastroenterol. 1996; 34: 497-508. German.
14. Marie I. [Gastrointestinal involvement in systemic sclerosis]. Presse Med. 2006; 35: 1952-1965. French.
15. LeRoy EC, Black CM, Fleischmajer R. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol. 1998; 15: 102-105.
16. Wang SJ, La JL, Chen DY, et al. Effects of Cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis. Clin Rheumatol. 2002; 21: 43-45.
17. Ebert EC. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol. 2008; 42: 5-12.
18. Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008; 53: 1163-1174.
19. Kawaguchi Y, Nakamura Y, Matsumoto I, et al. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility Ann Rheum Dis. 2009; 68: 710-714.
20. Manetti M, Neumann E, Milia AF, et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum. 2007; 56: 3442-3447. (Pubitemid 47585440)
21. Niemczyk M, Foroniewicz B, Mucha K. [The role of TGF-beta]. Pol Arch Med Wewn. 2005; 113: 401-414. Polish.
22. Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol. 1998; 93: 1453-1456. (Pubitemid 29075181)
23. Hirakata M, Akizuki M, Okano Y, et al. Pyloric stenosis in patient with progressive systemic sclerosis. Clin Rheumatol. 1988; 7: 394-397. (Pubitemid 19235979)
24. Airò P, Della Casa D, Danieli E, et al. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol. 2005; 24: 370-376. (Pubitemid 41102435)
25. Nishimagi E, Tochimoto A, Kawaguchi Y, et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol. 2007; 34: 2050-2055.
26. Tan EN. Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989; 44: 93-151.
27. Weiner ES, Earnshaw WC, Senecal JL, et al. Clinical association of anticentromere antibodies and antibodies to topoisomerase I. A study of 335 patients. Arthritis Rheum. 1988; 31: 378-385.
28. Savas N, Dagli U, Ertugrul E, et al. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations. Dig Dis Sci. 2007; 52: 3081-3086. (Pubitemid 47512563)